OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiac MRI Features and Prognostic Value in Immune Checkpoint Inhibitor–induced Myocarditis
Farah Cadour, Jennifer Cautela, Stanislas Rapacchi, et al.
Radiology (2022) Vol. 303, Iss. 3, pp. 512-521
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Cardiovascular complications of immune checkpoint inhibitors for cancer
Franck Thuny, Jarushka Naidoo, Tomas G. Neilan
European Heart Journal (2022) Vol. 43, Iss. 42, pp. 4458-4468
Open Access | Times Cited: 74

Immune checkpoints in cardiac physiology and pathology: therapeutic targets for heart failure
Tamás G. Gergely, Zsófia D. Drobni, Marinos Kallikourdis, et al.
Nature Reviews Cardiology (2024) Vol. 21, Iss. 7, pp. 443-462
Closed Access | Times Cited: 15

Immune Checkpoint Inhibitors-Associated Myocarditis: Diagnosis, Treatment and Current Status on Rechallenge
Federica Frascaro, Nicola Bianchi, Federico Sanguettoli, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 24, pp. 7737-7737
Open Access | Times Cited: 17

Cancer Treatment-Related Cardiovascular Toxicity in Gynecologic Malignancies
Susmita Parashar, Nausheen Akhter, Elisavet Paplomata, et al.
JACC CardioOncology (2023) Vol. 5, Iss. 2, pp. 159-173
Open Access | Times Cited: 16

Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors and CAR-T Cell Therapy: A Comprehensive Imaging-Based Review
Chiara Pozzessere, Bianca Mazini, Patrick Omoumi, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2585-2585
Open Access | Times Cited: 6

Complementary use of cardiac magnetic resonance and 18 F-FDG positron emission tomography imaging in suspected immune checkpoint inhibitor myocarditis
Jieli Tong, N. Vogiatzakis, María Sol Andrés, et al.
Cardio-Oncology (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 6

Cardiac magnetic resonance‐based layer‐specific strain in immune checkpoint inhibitor‐associated myocarditis
Zheng Li, Rui Zhao, Cong Wang, et al.
ESC Heart Failure (2024) Vol. 11, Iss. 2, pp. 1061-1075
Open Access | Times Cited: 5

Acute Myocarditis and Inflammatory Cardiomyopathies: Insights From Cardiac Magnetic Resonance Findings
Francesco Lauriero, Camilla Vittoria Vita, Alessio Perazzolo, et al.
Echocardiography (2025) Vol. 42, Iss. 2
Open Access

Immune checkpoint inhibitor-associated myocarditis: a review of current state of knowledge
Keila C. Ostos-Mendoza, Valeria Saraiba-Rabanales, Paola Gutierrez-Gallegos, et al.
The Journal of Cardiovascular Aging (2025) Vol. 5, Iss. 1
Open Access

Clinical Manifestations, Monitoring, and Prognosis: A Review of Cardiotoxicity After Antitumor Strategy
Wei Huang, Rong Xu, Bin Zhou, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 21

Diagnosis of cancer therapy-related cardiovascular toxicities: A multimodality integrative approach and future developments
Simon Travers, Joachim Alexandre, Lauren A. Baldassarre, et al.
Archives of cardiovascular diseases (2025)
Closed Access

Cardiac Imaging in Myocarditis: Current Evidence and Future Directions
Camila Urzua Fresno, Felipe Sánchez Tijmes, Kirsten E. Shaw, et al.
Canadian Association of Radiologists Journal (2022) Vol. 74, Iss. 1, pp. 147-159
Open Access | Times Cited: 18

Immune-Checkpoint Inhibitor-Related Myocarditis: Where We Are and Where We Will Go
Andrea Vergara, Marco De Felice, Arturo Cesaro, et al.
Angiology (2023) Vol. 75, Iss. 10, pp. 909-920
Closed Access | Times Cited: 9

What Is the Evidence of the Diagnostic Criteria and Screening of Immune Checkpoint Inhibitor–Induced Myocarditis?
Franck Thuny, Marc P. Bonaca, Jennifer Cautela
JACC CardioOncology (2022) Vol. 4, Iss. 5, pp. 624-628
Open Access | Times Cited: 15

Cardiotoxicity Induced by Immune Checkpoint Inhibitors: What a Cardio-Oncology Team Should Know and Do
Concetta Zito, Roberta Manganaro, Giuliana Ciappina, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5403-5403
Open Access | Times Cited: 14

Early evaluation of severe immune checkpoint inhibitor-associated myocarditis: a real-world clinical practice
Xin Tang, Yuan Li, He Huang, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 11, pp. 8345-8357
Closed Access | Times Cited: 8

Diagnostic Value of the International Society of Cardio‐Oncology Definition for Suspected Immune Checkpoint Inhibitor–Associated Myocarditis
Francois Deharo, Franck Thuny, Farah Cadour, et al.
Journal of the American Heart Association (2023) Vol. 12, Iss. 8
Open Access | Times Cited: 7

Predictors and Risk Score for Immune Checkpoint-Inhibitor-Associated Myocarditis Severity
John R. Power, Charles Dolladille, Adriel Procureur, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2

Diretriz de Tomografia Computadorizada e Ressonância Magnética Cardiovascular da Sociedade Brasileira de Cardiologia e do Colégio Brasileiro de Radiologia – 2024
Tiago Augusto Magalhães, Adriano Camargo de Castro Carneiro, Valéria de Melo Moreira, et al.
Arquivos Brasileiros de Cardiologia (2024) Vol. 121, Iss. 9
Open Access | Times Cited: 2

Cardiovascular Computed Tomography and Magnetic Resonance Imaging Guideline of the Brazilian Society of Cardiology and the Brazilian College of Radiology – 2024
Tiago Augusto Magalhães, Adriano Camargo de Castro Carneiro, Valéria de Melo Moreira, et al.
Arquivos Brasileiros de Cardiologia (2024) Vol. 121, Iss. 9
Open Access | Times Cited: 2

Multimodality imaging in cardio-oncology: the added value of CMR and CCTA
Costanza Lisi, Federica Catapano, Paolo Rondi, et al.
British Journal of Radiology (2023) Vol. 96, Iss. 1150
Open Access | Times Cited: 5

Overcoming the cardiac toxicities of cancer therapy immune checkpoint inhibitors
Omoruyi Credit Irabor, Nicolas G. Nelson, Yash Shah, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8

A Brain, A Heart, and the Courage: Balancing Benefit and Toxicity of Immunotherapy in Melanoma
Yen‐Chou Chen, Muhammad Jaffer, Lylybell Zhou, et al.
American Society of Clinical Oncology Educational Book (2023), Iss. 43
Open Access | Times Cited: 4

Page 1 - Next Page

Scroll to top